美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

INVESCO BIOTECHNOLOGY & GENOME ETF

93.64

+0.73000.79%

盤後：93.640.00000.00%16:10 EDT

成交量：5,448

成交額：50.88萬

市值：4.06億

市盈率：52.22

高：94.02

開：94.02

低：92.76

收：92.91

52周最高：98.82

52周最低：67.69

股本：434.00萬

流通股本：434.00萬

量比：0.45

換手率：0.13%

股息：1.55

股息率：1.66%

每股收益(TTM):1.79

每股收益(LYR):18.65

淨資產收益率：24.76%

總資產收益率：0.08%

市淨率：1.64

市盈率(LYR):5.02

資料載入中...

總覽公司新聞資訊公告

美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創

安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。

富國銀行上調安進目標價至435美元

諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

Stoke Therapeutics與渤健在第16屆歐洲癲癇大會上公布Zorevunersen長期臨床數據，力證Dravet綜合徵治療藥物的疾病修飾潛力

阿爾尼拉姆製藥公司(ALNY)股票9月2日盤中上漲7.90%：釋放什麼信號？

TradingKey中文

梯瓦製藥（TEVA）與Royalty Pharma（RPRX）合作抗體藥物TEV'408迎重大臨床突破

特瓦公司一款免疫系統疾病藥物在中期臨床試驗中達到了主要目標

安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可

高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯

高盛9月「確信名單」更新：美股納入福泰製藥歐股力推萊茵、Adyen和塔蘭克斯

美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極

英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者

英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor

衞材宣佈：加拿大藥品管理局最終推薦侖卡奈單抗（Leqembi）在早期阿爾茨海默病中獲得報銷資格

特朗普政府將宣佈藥品定價協議

安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險

藥聞 | 英硅智能上市後首份半年報扭虧創新藥研發加速擁抱AI

樂意保®（侖卡奈單抗）皮下自動注射劑型LEQEMBI IQLIK®在美上市，適用於早期阿爾茨海默病的初始治療

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PBE/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":93.64,"timestamp":1789416000000,"preClose":92.91,"halted":0,"volume":5448,"hourTrading":{"tag":"盘后","latestPrice":93.64,"preClose":93.64,"latestTime":"16:10 EDT","volume":7,"amount":655.77995,"timestamp":1789416604483,"change":0,"changeRate":0,"amplitude":0.001602},"delay":0,"changeRate":0.00785706597782805,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"盤後交易","change":0.73,"latestTime":"09-14 16:39:09 EDT","open":94.02,"high":94.02,"low":92.7601,"amount":508797,"amplitude":0.01356,"askPrice":99.98,"askSize":30,"bidPrice":84.82,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":92.91,"sharesOutstanding":3180000,"nav":93.09028,"aum":404801564.79,"dividendRate":0.01657,"bidAskSpread":0.002045,"postHourTrading":{"tag":"盘后","latestPrice":93.64,"preClose":93.64,"latestTime":"16:10 EDT","volume":7,"amount":655.77995,"timestamp":1789416604483,"change":0,"changeRate":0,"amplitude":0.001602},"volumeRatio":0.44504,"impliedVol":0.0984,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.44504,"shares":4340000,"dividePrice":1.5516,"high":94.02,"amplitude":0.01356,"preClose":92.91,"low":92.7601,"week52Low":67.69,"pbRate":"1.64","psRate":"236.74","week52High":98.82,"institutionHeld":0.2552,"latestPrice":93.64,"committee":0.538462,"eps":1.793292,"divideRate":0.01657,"volume":5448,"delay":0,"ttmEps":1.793292,"open":94.02,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":97.6367,"twentyDayClose":93.7443,"sixtyDayClose":84.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665326953","title":"美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1983299246.USD","BK4007","BK4566","LU0122379950.USD","LU0320765992.SGD","BK4581","BK4533","LU2468319806.SGD","PPH","LU0211331839.USD","IE00BJT1NW94.SGD","BK4578","LU0320765489.SGD","BK4585","IBBQ","BK4534","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0070302665.USD","AMGN","IBB","LU0868494617.USD","BK4588","LU1057294990.SGD","LU0889565916.HKD","IE00B2B36J28.USD","LU0109394709.USD","BK4532","BBH","LU0289739699.SGD","IE0009355771.USD","LU1061106388.HKD","LU0058720904.USD","PBE","BK4599","BIB","NVS","LU2089984988.USD","MEDX","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","PJP","LU2112291526.USD","LU1023059063.AUD","BK4139","TBXU","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安進股價盤前下跌5.4%；競爭對手諾華的膽固醇藥物後期臨床試驗失敗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665258833?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IE00BJJMRZ35.SGD","AMGN","BK4566","LU0109394709.USD","LU1057294990.SGD","PPH","PSYK","LU2468319806.SGD","LU2112291526.USD","BK4581","IE00BJT1NW94.SGD","BIB","PJP","LU0889565916.HKD","IE0002141913.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0320765992.SGD","BBH","LU0208291251.USD","BK4588","BK4533","BMED","LU1023059063.AUD","LU0058720904.USD","LU0868494617.USD","BK4532","IBBQ","LU2242646821.SGD","LU0289739699.SGD","IBB","LU1983299246.USD","BK4007","IBBJ","NVS","PBE","BK4578","LU1061106388.HKD","LU0320765489.SGD","MDTX","LU0070302665.USD","LU0211331839.USD","BK4534","BK4585","TBXU","SG9999001440.SGD","LU2089984988.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富國銀行上調安進目標價至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UDN","BK4566","AMGN","UUP","IE00B2B36J28.USD","LU1571399168.USD","LU1061106388.HKD","LU2468319806.SGD","LU0889565916.HKD","BK4139","BK4533","LU1057294990.SGD","BK4582","BIB","IE00B4R5TH58.HKD","LU0109394709.USD","LU1983299246.USD","LU2112291526.USD","BBH","IE00BFTCPJ56.SGD","IBB","PGF","IE0009355771.USD","PBE","LU1023059063.AUD","LU0058720904.USD","PJP","LU2242646821.SGD","BK4585","LU0868494617.USD","BK4534","LU2242652126.USD","BK4581","LU0289739699.SGD","LU2089984988.USD","SG9999001440.SGD","LU0320765992.SGD","IE0002141913.USD","BK4599","IE00BJJMRZ35.SGD","LU0122379950.USD","TBXU","IBBQ","IE00BJT1NW94.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","LU1988902786.USD","MEDX","THNR","LLY","AGNG","IBB","WDNA","LLII","LU2324357040.USD","IXJ","FHLC","MHIP","BK4581","LU1551013425.SGD","IBBQ","ELIL","IYH","BK4588","LLYZ","BIB","PPH","OZEM","RXL","VHT","PBE","ELIS","AMGN","IHE","NAMS","TBXU","BBH","FTXH","LLYX","LU2746668974.SGD","MEDI","CURE","CANC","GDOC","XLV","LU0096364046.USD","IE00BK4W5L77.USD","TMED","TRUH","LU0456855351.SGD","PJP","JDOC","HRTS","SLN","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BIB","LU0058720904.USD","IE0009355771.USD","BK4533","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4007","LU1057294990.SGD","MEDX","LU2242652126.USD","SG9999001440.SGD","BK4599","LU0070302665.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0889565916.HKD","LU0211331839.USD","LU2089984988.USD","LU1061106388.HKD","AMGN","BK4532","BK4139","LU2242646821.SGD","BK4585","LU2112291526.USD","LU0320765489.SGD","TBXU","IE00B2B36J28.USD","LU0122379950.USD","BK4566","IE00B4R5TH58.HKD","LU1571399168.USD","LU2468319806.SGD","PBE","LU0320765992.SGD","IBBQ","BK4588","LU0289739699.SGD","LU0868494617.USD","NVS","PPH","PJP","LU1023059063.AUD","BK4581","IBB","BK4534","BK4578","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194645441","title":"Stoke Therapeutics與渤健在第16屆歐洲癲癇大會上公布Zorevunersen長期臨床數據，力證Dravet綜合徵治療藥物的疾病修飾潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194645441","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194645441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 07:31","pubTimestamp":1788478271,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics与渤健公司于第16届欧洲癫痫大会上联合呈现了Zorevunersen的长期临床数据，这些数据有力支持了这款用于治疗Dravet综合征的在研药物所具备的疾病修饰潜力。Zorevunersen作为一种实验性疗法，其最新公布的长期随访结果备受业界关注。此次大会上披露的数据，进一步印证了该药物在改变Dravet综合征疾病进程方面的可能性，为这一罕见且严重的癫痫性脑病治疗领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","IE00B19Z9P08.USD","BK4585","LU0889565916.HKD","PBE","BK4532","BIIB","LU0109394709.USD","BK4533","LU0320765992.SGD","BK4139","IE00B19Z9Z06.USD","LU0234570918.USD","BMED","STOK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664143843","title":"阿爾尼拉姆製藥公司(ALNY)股票9月2日盤中上漲7.90%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664143843","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664143843?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 00:16","pubTimestamp":1788365792,"startTime":"0","endTime":"0","summary":"• 受到积极临床数据及华尔街分析师正面看好的提振，Alnylam股价大幅上涨。\n• Amvuttra在治疗心肌病方面展现出卓越疗效和强劲的临床试验结果。\n• 该公司报告年收入为37.1亿美元，技术指标呈中性。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262146919-market-movers-alny-20260902","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4548","LU0114720955.EUR","LU0320765992.SGD","LU0882574055.USD","BK4585","GNMX","PBE","BK4139","BK4588","ALNY","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333811","title":"梯瓦製藥（TEVA）與Royalty Pharma（RPRX）合作抗體藥物TEV'408迎重大臨床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333811","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664333811?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:07","pubTimestamp":1788350836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 梯瓦制药 与Royalty Pharma宣布，双方合作开发的抗白细胞介素-15抗体药物TEV'408在治疗成人乳糜泻的2a期临床试验中取得积极结果。在给药第8周时，与安慰剂组相比，TEV'408在统计学上显著且临床上有效地预防了由麸质诱发的肠道损伤。根据“乳糜泻症状日记”显示，接受TEV'408治疗的患者其胃肠道症状评分明显低于安慰剂组。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4559","BK4585","LU2324357040.USD","BK4584","BK4596","TEVA","IHE","PBE","BK4557","RPRX","BK4588","BK4566","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081923","title":"特瓦公司一款免疫系統疾病藥物在中期臨床試驗中達到了主要目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081923?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:02","pubTimestamp":1788350525,"startTime":"0","endTime":"0","summary":"特瓦公司一款免疫系统疾病药物在中期临床试验中达到了主要目标路透9月2日-以色列制药商梯瓦制药工业公司周三表示，其一款试验性药物有助于预防成人乳糜泻患者因麸质引发的肠道损伤，达到了中期临床试验的主要目标。乳糜泻是一种自身免疫性疾病，其中麸质会引发免疫反应，从而损伤小肠。TEV-408目前还正在针对白癜风进行测试，并计划针对该皮肤病启动另一项中期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4T44U120:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4596","BK4588","BK4557","RPRX","IHE","PBE","BK4007","BK4559","LU1983299246.USD","BK4585","TEVA","LU2324357040.USD","BK4566","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安進（AMGN）罕見病藥物Tavneos將於27年3月1日被徹底撤銷英國上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664194548?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","AZNH","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","PBE","LU2112291526.USD","BK4533","LU0058720904.USD","LU2468319806.SGD","LU2089984988.USD","PJP","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","LU2242652126.USD","LU0289739699.SGD","LU0868494617.USD","LU1061106388.HKD","BK4581","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","IPOS","BK4566","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","LU2242646821.SGD","BBH","BIB","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月「確信名單」更新：美股納入福泰製藥(VRTX.US) 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891714?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1144417596.USD","LU1868836591.USD","LU0432979614.USD","LU2237443549.SGD","BK4127","LU2324357040.USD","LU1674673691.USD","LU0868494617.USD","LU2471134952.CNY","BK4588","BBH","LU1868836914.USD","PBE","BIB","VXUS","TBXU","BK4585","LU0868494708.USD","IE0002141913.USD","LU0061475181.USD","LU1791807156.HKD","LU0289739699.SGD","IBB","LU0942090050.USD","SG9999001176.USD","LU0251131958.USD","IE00B19Z9P08.USD","VRTX","IE00BJJMRZ35.SGD","LU2462157665.USD","IBBQ","IE00B19Z9Z06.USD","LU2237438978.USD","LU2468319806.SGD","LU2456880835.USD","IE0009355771.USD","SG9999001176.SGD","LU2237443978.SGD","GSX","GNMX","IEV","VGK","LU1868837300.USD","LU0096364046.USD","LU2471134523.USD","IDNA","BK4550","BK4533","IE00BZ9MQY76.HKD","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月「確信名單」更新：美股納入福泰製藥 歐股力推萊茵、Adyen和塔蘭克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891705?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034235188.USD","XYZ","IBBQ","CRNX","BIB","LU0345770993.USD","LU2471134523.USD","GNMX","LU1868836757.USD","LU2236285917.USD","COP","IE00B19Z3581.USD","MSFX","UNHW","LU2362541273.HKD","XYZG","LU0106831901.USD","DAL","LU2456880835.USD","IBB","BK4504","GSX","LU2471134796.USD","UNHG","IBKR","IE00BFTCPJ56.SGD","BK4567","LU1868837136.USD","LU1868837300.USD","IE00B2B36J28.USD","LU2471134952.CNY","PBE","BK4533","LU0109394709.USD","SG9999001176.USD","LU2471134879.HKD","MSFU","EL","SG9999001176.SGD","BBH","LU2468319806.SGD","IE00BJT1NW94.SGD","MSFL","UN","MSFD","LU1585245621.USD","MSFY","IE0002270589.USD","MSFC","XYZY","MSFW","IE0004091025.USD","LU0889565916.HKD","VXUS","LU2265009873.SGD","VRTX","LU2417539215.USD","IE00BFXG1179.USD","BK4585","IEV","TBXU","LU2237443549.SGD","BK4532","VGK","MSFT","UNH","LU0432979614.USD","LU2750360641.GBP","IDNA","MSFO","UNHU","WFC","LU1069344957.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","BBP","MEDX","RSPH","IBB","GNOM","WDNA","IE00BFTCPJ56.SGD","MRNX","PBPH","PSCH","IBRN","IE00B4R5TH58.HKD","IYH","BK4588","SYNB","BIB","PPH","LU2322448957.HKD","RXL","IEHS","PBE","HELX","SBIO","AZNH","BK4585","IE0009355771.USD","LFSC","MRNY","LU2473716301.USD","IE0002141913.USD","NVS","BBH","FTXH","LU2272731600.USD","IE00BJT1NW94.SGD","XPH","MEDI","CANC","FBT","LU0211331839.USD","XBIX","BIOY","LU0070302665.USD","TMED","PJP","IEIH","IE00BJJMRZ35.SGD","IDNA","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","PBE","BK4566","IE00BJJMRZ35.SGD","LU2089984988.USD","BK7501","BBH","LU0122379950.USD","TBXU","LU1057294990.SGD","BK7511","BK4588","AMGN","BK7508","LU2468319806.SGD","SG9999001440.SGD","IBB","LU2242646821.SGD","LU2242652126.USD","LU0320765992.SGD","PJP","BK7067","BK4139","IE00B2B36J28.USD","LU0109394709.USD","IE0002141913.USD","LU2112291526.USD","CSL.AU","LU0889565916.HKD","BK4581","LU1983299246.USD","BK4533","BK4585","LU1061106388.HKD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0868494617.USD","BIB","BK4599","BK4534","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0289739699.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局（MHRA）已正式告知上市许可持有方，关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节，意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4581","PJP","BK4599","LU1571399168.USD","TBXU","IE0002141913.USD","BBH","LU0889565916.HKD","LU2468319806.SGD","IBB","BK4585","PBE","LU0868494617.USD","SG9999001440.SGD","LU1983299246.USD","LU1061106388.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU2242652126.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139","LU1023059063.AUD","IE00BJT1NW94.SGD","IBBQ","LU2089984988.USD","BK4588","AMGN","LU0320765992.SGD","BIB","BK4566","LU0122379950.USD","BK4533","LU0058720904.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110244724","title":"衞材宣佈：加拿大藥品管理局最終推薦侖卡奈單抗（Leqembi）在早期阿爾茨海默病中獲得報銷資格","url":"https://stock-news.laohu8.com/highlight/detail?id=1110244724","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110244724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:08","pubTimestamp":1788199690,"startTime":"0","endTime":"0","summary":"卫材今日宣布，加拿大药品管理局已就仑卡奈单抗在早期阿尔茨海默病治疗中的报销事宜发布最终积极推荐。这一决定意味着，符合条件的加拿大患者将有望获得这一创新疗法的公共资金支持。加拿大药品管理局经过严谨的临床证据评估后，最终给出了肯定意见。卫材公司表示，将继续与加拿大各省及地区的卫生部门密切协作，推动报销政策的实际落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","BK4139","PBE","IE00B19Z9P08.USD","LU0234570918.USD","LU0889565916.HKD","BK4533","IE00B894F039.SGD","LU0320765992.SGD","BK4532","BMED","IE00B19Z9Z06.USD","BK4585","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普  预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0133085943.USD","LU2750360997.AUD","LU1712237335.SGD","LU2360106947.USD","IXJ","LU2602419157.SGD","LU0109391861.USD","SG9999002232.USD","LU0882574139.USD","LU2756315664.SGD","LU2112291526.USD","LU2237438978.USD","BK4516","LU0353189763.USD","LU1291159041.SGD","IE0004445015.USD","PJP","IE0005OL40V9.USD","LU2108987350.USD","LU2896262040.SGD","SG9999001440.SGD","IE00B19Z3B42.SGD","LU1983299246.USD","LU2471134796.USD","IE00BN29S564.USD","LU2471134523.USD","SG9999014898.SGD","BK4592","LU0456855351.SGD","LU2324357040.USD","SG9999015978.USD","LU1629891620.HKD","BK7511","MEDX","BIB","LU0321505439.SGD","LU1066051498.USD","LU1267930730.SGD","LU1366192091.USD","CURE","LU0114720955.EUR","IE00BK4W5M84.HKD","LU0708995401.HKD","GB00BDT5M118.USD","LU2461242641.AUD","LU2361044865.SGD","LU1232071149.USD","LU2471134879.HKD","IE0002270589.USD","IYH","LU2242652126.USD","LU1061106388.HKD","LU2468319806.SGD","LU2552382058.USD","BK7501","FTXH","SG9999014906.USD","CANC","LU1868837300.USD","LU2089984988.USD","BK4007","LU0079474960.USD","LU1623119135.USD","LU2236285917.USD","LU0640476718.USD","IE00B775H168.HKD","LU0158827781.USD","MHIP","IE00B7KXQ091.USD","IE000M9KFDE8.USD","LU0198837287.USD","LU2213496289.HKD","LU0225283273.USD","SG9999018857.SGD","SG9999003800.SGD","ELIL","TMED","IE00B3T34201.USD","LLY","LU2756315318.SGD","LU2028103732.USD","IE00BJT1NW94.SGD","ILDR","IE00BFSS7M15.SGD","LU2023250330.USD","LU1057294990.SGD","BK4533","LU0203202063.USD","SG9999015986.USD","LU0006306889.USD","LU0170899867.USD","LU0345770308.USD","LU0353189680.USD","LU0985481810.HKD","LU2552382132.HKD","LU1720051017.SGD","LU0823416689.USD","LU0868494617.USD","LU0432979614.USD","LU0210536198.USD","IE00BKPKM429.USD","LU1548497426.USD","LU2462157665.USD","SGXZ51526630.SGD","LU1023059063.AUD","LU0417517546.SGD","LU1988902786.USD","04332","LU0306806265.USD","LU2106854487.HKD","LU2750360641.GBP","LU2089283258.USD","LU0316494557.USD","LU2023250504.SGD","LU1804176565.USD","IHE","LU1868836591.USD","LU2237443382.USD","LU1093756168.USD","LU1814569148.SGD","LU0823434740.USD","BK4139","BK4550","LU0823434583.USD","LU2111349929.HKD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0106261372.USD","AGNG","LU2211815571.USD","IE00BLSP4239.USD","LU2242646821.SGD","SG9999015952.SGD","LU1093756325.SGD","SG9999011175.SGD","IE00BJLML261.HKD","LU1035775433.USD","LU0471298694.HKD","LU0345770993.USD","LU2491050154.USD","LU0058720904.USD","PFE","IE00BJJMRX11.SGD","IE00B4R5TH58.HKD","LU2491049909.HKD","WDNA","LU2168564222.USD","HRTS","LU2417539215.USD","LU0266013472.USD","LU0323591593.USD","LU1064131342.USD","LU1883839398.USD","LU1145028129.USD","LU0889565916.HKD","LU2491050071.SGD","LU0096364046.USD","RXL","SGXZ31699556.SGD","LU0122379950.USD","LLII","LU2063271972.USD","IE0001KFT4U8.USD","LU0321505868.SGD","LU0354030438.USD","LU0354030511.USD","SG9999015945.SGD","SGXZ81514606.USD","LU0964807845.USD","IBBQ","LU0256863902.USD","LU2471134952.CNY","LU2746668974.SGD","PBE","CSL.AU","LU0238689110.USD","OZEM","LU2462591350.SGD","AMGN","LU0225771236.USD","LU0786609619.USD","LU2746668461.USD","IE00B2B36J28.USD","LU0306807586.USD","LU2271345857.HKD","LU0787776722.HKD","LU2357305700.SGD","LU1979441026.SGD","BK7508","TBXU","LU1069344957.HKD","LU1989771016.USD","IE00BWXC8680.SGD","LU2361044949.HKD","FHLC","SG9999002224.SGD","JDOC","LU2237443549.SGD","LLYX","LU0203201768.USD","LU0234572021.USD","MEDI","SG9999014880.SGD","LU2361045086.USD","BK4534","IE00BLSP4452.SGD","LU0109394709.USD","LU1551013342.USD","BK4585","IE00BKDWB100.SGD","SG9999017495.SGD","BK4581","LU0225284248.USD","SG9999001176.SGD","LU0672654240.SGD","LU1720051108.HKD","IE00B4JS1V06.HKD","LU2237443622.USD","LU2265009873.SGD","LU0320765059.SGD","LU1974910355.USD","LU0471298777.SGD","BK4566","IE0004445239.USD","LU1323610961.USD","LU2087625088.SGD","ELIS","LU2168564065.EUR","GDOC","IE0002141913.USD","PPH","LU2168563687.JPY","LU0256863811.USD","BK4599","LU1868836757.USD","LU1571399168.USD","LU2023251221.USD","LU1127390331.HKD","SGXZ99366536.SGD","VHT","IE0009355771.USD","LU0943347566.SGD","LU0097036916.USD","LU1066053197.SGD","LU2456880835.USD","IE00BK4W5L77.USD","LU2168564149.EUR","SG9999001176.USD","XLV","LU0683600562.USD","LU2264538146.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU2089284900.SGD","LU2552382215.SGD","LU1894683348.USD","SG9999014914.USD","IE00B19Z3581.USD","IE00B1XK9C88.USD","LU2596442595.SGD","BK7067","LU0094547139.USD","BK4568","LU1691799644.USD","LU1868837136.USD","IE00BFSS8Q28.SGD","IE00B1BXHZ80.USD","BK4588","LU0289739699.SGD","SG9999018865.SGD","TRUH","LU2237443895.HKD","LU0882574055.USD","LU0820562030.AUD","LU1280957306.USD","LU0820561818.USD","LU0158827948.USD","LU2237443978.SGD","IONS","LU0820561909.HKD","THNR","LU0689472784.USD","LU1894683264.USD","LU2237443465.HKD","LU0061475181.USD","LU0385154629.USD","LU2168564495.EUR","LU1551013425.SGD","LLYZ","LU0174119429.USD","LU1917777945.USD","SG9999013999.USD","LU0320765992.SGD","IE00BJJMRY28.SGD","IE00BFTCPJ56.SGD","LU0466842654.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663778550","title":"安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示，对于既往未发生过心肌梗死或中风的高危成年患者，在接受他汀类或其他降脂疗法的基础上加用Repatha，可显著降低20%的全因死亡风险，同时有效降低心血管死亡率。数据显示，Repatha能在治疗开启最早6个月内降低心梗风险，且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL，远优于安慰剂组的109mg/dL。此外，欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症，用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1983299246.USD","AMGN","BK4581","LU2468319806.SGD","LU2242646821.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE0002141913.USD","LU1057294990.SGD","LU2089984988.USD","LU2112291526.USD","BIB","BK4588","LU2242652126.USD","LU1061106388.HKD","BK4566","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","IBB","PBE","PJP","IBBQ","BBH","TBXU","IE00BJT1NW94.SGD","BK4139","LU0868494617.USD","LU1023059063.AUD","SG9999001440.SGD","BK4534","BK4599","LU0109394709.USD","LU0122379950.USD","BK4533","IE0009355771.USD","BK4585","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CHAT","QTOC","BIOY","AGIX","GDOC","IPOS","LFSC","WRND","GSKH","APXH","BBP","BK4585","SBIO","IBB","XLVI","ARTY","AIPO","PBE","VTHR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663734390","title":"樂意保®（侖卡奈單抗）皮下自動注射劑型LEQEMBI IQLIK®在美上市，適用於早期阿爾茨海默病的初始治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2663734390","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663734390?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:47","pubTimestamp":1788158820,"startTime":"0","endTime":"0","summary":"乐意保皮下自动注射剂型已获美国FDA批准，是全球首个可为初始治疗和维持治疗提供居家给药选择的抗淀粉样蛋白疗法。贯穿阿尔茨海默病治疗全程，提升治疗便利性与灵活性 在美国，乐意保皮下自动注射剂型已可用于初始治疗及维持治疗。该剂型有望进一步提升治疗的便利性和灵活性，使早期阿尔茨海默病患者及其照护伙伴在疾病管理中获得更大的自主权，同时可能降低患者启动和持续使用乐意保治疗的阻碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5036748_ZH36748_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5036748_ZH36748_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IE00B894F039.SGD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","IPOS","LU0109394709.USD","BIIB","BK4585","BK4588","LU0889565916.HKD","LU0234570918.USD","BK4533","PBE","LU0320765992.SGD","BK4139","BMED","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":149,"code":"91000000","status":"200"}]}}